Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)
Clinical trial NCT02618434 · COMPLETED
Trial details
- NCT number
- NCT02618434
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-16
- Primary completion
- 2019-11-15
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.